112 related articles for article (PubMed ID: 9178317)
1. Microsatellite markers in the indirect analysis of the steroid 21-hydroxylase gene.
Ezquieta B; Jariego C; Varela JM; Oliver A; Gracia R
Prenat Diagn; 1997 May; 17(5):429-34. PubMed ID: 9178317
[TBL] [Abstract][Full Text] [Related]
2. Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis.
Lako M; Ramsden S; Campbell RD; Strachan T
J Med Genet; 1999 Feb; 36(2):119-24. PubMed ID: 10051010
[TBL] [Abstract][Full Text] [Related]
3. Prenatal diagnosis of 21-hydroxylase deficiency caused by gene conversion and rearrangements: pitfalls and molecular diagnostic solutions.
Mao R; Nelson L; Kates R; Miller CE; Donaldson DL; Tang W; Ward K
Prenat Diagn; 2002 Dec; 22(13):1171-6. PubMed ID: 12478627
[TBL] [Abstract][Full Text] [Related]
4. E380D: a novel point mutation of CYP21 in an HLA-homozygous patient with salt-losing congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Kirby-Keyser L; Porter CC; Donohoue PA
Hum Mutat; 1997; 9(2):181-2. PubMed ID: 9067760
[No Abstract] [Full Text] [Related]
5. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees.
Day DJ; Speiser PW; Schulze E; Bettendorf M; Fitness J; Barany F; White PC
Hum Mol Genet; 1996 Dec; 5(12):2039-48. PubMed ID: 8968761
[TBL] [Abstract][Full Text] [Related]
6. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
Wedell A
Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
[TBL] [Abstract][Full Text] [Related]
7. Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study.
Manfras BJ; Swinyard M; Rudert WA; Ball EJ; Lee PA; Kühnl P; Trucco M; Böhm BO
Hum Genet; 1993 Aug; 92(1):33-9. PubMed ID: 8365724
[TBL] [Abstract][Full Text] [Related]
8. The implication of de novo 21-hydroxylase mutation in clinical and prenatal molecular diagnoses.
Mao R; McDonald J; Cantwell M; Tang W; Ward K
Genet Test; 2005; 9(2):121-5. PubMed ID: 15943551
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
Vakili R; Baradaran-Heravi A; Barid-Fatehi B; Gholamin M; Ghaemi N; Abbaszadegan MR
Horm Res; 2005; 63(3):119-24. PubMed ID: 15775714
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
11. de novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblings.
Tajima T; Fujieda K; Fujii-Kuriyama Y
J Clin Endocrinol Metab; 1993 Jul; 77(1):86-9. PubMed ID: 8325964
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphisms in intron 2 of CYP21P: evidence for a higher rate of mutation at CpG dinucleotides in the functional steroid 21-hydroxylase gene and application to segregation analysis in congenital adrenal hyperplasia.
Jiddou RR; Wei WL; Sane KS; Killeen AA
Clin Chem; 1999 May; 45(5):625-9. PubMed ID: 10222348
[TBL] [Abstract][Full Text] [Related]
13. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
Owerbach D; Ballard AL; Draznin MB
J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489
[TBL] [Abstract][Full Text] [Related]
14. Characterization of frequent polymorphisms in intron 2 of CYP21: application to analysis of segregation of CYP21 alleles.
Killeen AA; Jiddou RR; Sane KS
Clin Chem; 1998 Dec; 44(12):2410-5. PubMed ID: 9836705
[TBL] [Abstract][Full Text] [Related]
15. [Genetic of the 21 hydroxylase deficiency].
Boué A; Couillin P; Pomarède R; Rappaport R; Boué J
Ann Endocrinol (Paris); 1982; 43(1):3-14. PubMed ID: 6982657
[TBL] [Abstract][Full Text] [Related]
16. Gene conversion (655G splicing mutation) and the founder effect (Gln318Stop) contribute to the most frequent severe point mutations in congenital adrenal hyperplasia (21-hydroxylase deficiency) in the Spanish population.
Ezquieta B; Cueva E; Oyarzábal M; Oliver A; Varela JM; Jariego C
Clin Genet; 2002 Aug; 62(2):181-8. PubMed ID: 12220458
[TBL] [Abstract][Full Text] [Related]
17. A novel semiquantitative polymerase chain reaction/enzyme digestion-based method for detection of large scale deletions/conversions of the CYP21 gene and mutation screening in Turkish families with 21-hydroxylase deficiency.
Tukel T; Uyguner O; Wei JQ; Yuksel-Apak M; Saka N; Song DX; Kayserili H; Bas F; Gunoz H; Wilson RC; New MI; Wollnik B
J Clin Endocrinol Metab; 2003 Dec; 88(12):5893-7. PubMed ID: 14671187
[TBL] [Abstract][Full Text] [Related]
18. Molecular genetic prenatal diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency by allele-specific hybridization.
Speiser PW; White PC; Dupont J; Zhu D; Mercado A; New MI
Recent Prog Horm Res; 1994; 49():367-71. PubMed ID: 8146433
[TBL] [Abstract][Full Text] [Related]
19. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
20. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
